Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation
References (20)
- et al.
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent AFa randomized, double-blind, placebo-controlled study
J Am Coll Cardiol
(2000) - et al.
Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent AF
Am J Cardiol
(2003) - et al.
Amiodarone as a first choice drug for restoring sinus rhythm in patients with AF
Chest
(2000) - et al.
Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes
Eur J Pharmacol
(1999) - et al.
Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy
Pacing Clin Electrophysiol
(2003) - et al.
Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic AF
Eur Heart J
(2000) - et al.
Low dose amiodarone for maintenance of sinus rhythm after conversion of AF or flutter
JAMA
(1992) - et al.
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure
N Engl J Med
(1995) - et al.
An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal AF
Heart
(1999) - et al.
Maintenance of sinus rhythm after electrical cardioversion of persistent AF; sotalol vs bisoprolol
Eur Heart J
(2001)
Cited by (36)
Atrial Fibrillation: Antiarrhythmic Therapy
2014, Current Problems in CardiologyCitation Excerpt :In a later trial, with 4 weeks of pretreatment and an approximate 8-g oral load, amiodarone and carvedilol both raised the cardioversion rate from 73% to 93%.47,53 However, a month after conversion 39% of patients in the placebo group, 28% of patients treated with carvedilol, and 17% of patients on amiodarone reverted to AF.53 Amiodarone pretreatment also reduced the total energy needed for successful cardioversion.
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2011, Journal of the American College of CardiologyCitation Excerpt :Prophylactic treatment with amiodarone was also effective when an initial attempt at direct-current cardioversion had failed (531,569). In patients with persistent AF randomly assigned to treatment with carvedilol, amiodarone, or placebo for 4 wk before direct-current cardioversion, the 2 drugs yielded similar cardioversion rates, but amiodarone proved superior at maintaining sinus rhythm after conversion (707). Although beta blockers are unlikely to enhance the success of cardioversion or to suppress immediate or late recurrence of AF, they may reduce subacute recurrences (583).
Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation
2007, American Heart JournalCitation Excerpt :Amiodarone has been recommended as first-line therapy for maintenance of sinus rhythm in both the ACC/AHA/ESC guidelines and the American Academy of Family Physicians and the American College of Physician guidelines in selected patients.4,9 Although, several studies have documented its effectiveness and efficacy in managing atrial fibrillation,19-23 amiodarone does not have a Food and Drug Administration (FDA)–approved indication for use in the management of atrial fibrillation. In fact, in December 2004, the FDA required that all prescriptions of amiodarone be dispensed with a medication guide.
Effect of amiodarone treatment on outcome after direct current cardioversion in atrial fibrillation: Should we cardiovert atrial fibrillation of longer duration
2007, International Journal of CardiologyCitation Excerpt :Greater proportion of patients with AF of longer duration remained in SR when treated with amiodarone compared to other treatment but the difference was not significant, which could be because of the small number of patients studied. When compared with other antiarrhythmics, amiodarone has been found to be superior in maintaining sinus rhythm [2,4]. Channer et al. reported trend for greater efficacy with amiodarone continued for 1 year after cardioversion [5].
ECG based assessment of circadian variation in AV-nodal conduction during AF—Influence of rate control drugs
2022, Frontiers in PhysiologyAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2019, Cochrane Database of Systematic Reviews